Back to Browse Journals » Patient Preference and Adherence » Volume 2

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers

Authors Carole Decker, Linda Garavalia, Brian Garavalia, John A Spertus

Published 3 June 2008 Volume 2008:2 Pages 167—175


Review by Single-blind

Peer reviewer comments 3

Carole Decker1, Linda Garavalia2, Brian Garavalia1, John A Spertus1

1Mid America Heart Institute, Saint Luke’s Hospital, Kansas City, MO, USA; 2Department of Psychology, University of Missouri, Kansas City, MO, USA

Background: Each day, patients make choices whether or not to take their prescribed medications. Previous research has shown that 1 in 7 myocardial infarction (MI) patients discontinued thienopyridines within 1 month of receiving a drug-eluting stent (DES) with serious consequences. This qualitative research study explored in depth the clopidogrel-taking behavior among DES-treated patients who quit taking clopidogrel 1 month after treatment and those who continued therapy.

Methods: Sequential patients from a prospective MI registry who reported discontinuing clopidogrel within 30 days of DES treatment (N = 11) were matched with continuers (N = 11). Both groups underwent detailed qualitative phone interviews. Coding and thematic representation using directed qualitative content analysis by 3 PhD researchers was done.

Results: Patients were 41–77 years old and the majority was Caucasian and male. Multiple barriers were described by discontinuers that were not reported by continuers. The most frequently cited barrier was misunderstanding the intended duration of treatment. Discontinuers also described system weaknesses that contributed to early discontinuance such as gaps in the transition to primary care.

Conclusions: While premature discontinuation of a prescribed therapy is viewed by clinicians as a willful disregard for medical advice, early stopping of clopidogrel is influenced greatly by processes of care and system issues.

Keywords: medication discontinuance, drug-eluting stent post-care, myocardial infarction

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians

Decker C, Garavalia L, Garavalia B, Simon T, Loeb M, Spertus J, Daniel WC

Journal of Multidisciplinary Healthcare 2012, 5:129-135

Published Date: 13 June 2012

Readers of this article also read:

Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro

Kazuhito Asano, Yusuke Shikama, Yasuhiro Shibuya, Hiroaki Nakajima, Ken-ichi Kanai, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:781-790

Published Date: 5 December 2008

Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences

Carlos Zamarrón, Vanesa García Paz, Emilio Morete, Felix del Campo Matías

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:671-682

Published Date: 5 December 2008

Aberrant positioning of a central venous dialysis catheter to reveal a left-sided partial anomalous pulmonary venous connection

Manohar R Chintu, Shammikumar Chinnappa, Sunil Bhandari

Vascular Health and Risk Management 2008, 4:1141-1143

Published Date: 10 October 2008

Patient’s compliance with allergen immunotherapy

Cristoforo Incorvaia, Marina Mauro, Erminia Ridolo, Paola Puccinelli, Massimiliano Liuzzo, et al

Patient Preference and Adherence 2008, 2:247-251

Published Date: 15 September 2008

New combination treatments in the management of diabetes: focus on sitagliptin – metformin

Jennifer Green, Mark Feinglos

Vascular Health and Risk Management 2008, 4:743-751

Published Date: 8 August 2008

A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient

Mary Ann Sevick, Roslyn A Stone, Matthew Novak, Beth Piraino, Linda Snetselaar, et al

Patient Preference and Adherence 2008, 2:177-184

Published Date: 2 July 2008

Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection

Domenico Lumia, Gianpaolo Carrafiello, Domenico Laganà, Andrea Musazzi, Andrea Giorgianni, et al

Vascular Health and Risk Management 2008, 4:735-739

Published Date: 6 June 2008

Patients’ perception of diagnostic tests in the preoperative assessment of esophageal cancer

Marinke Westerterp, Henderik L van Westreenen, Marije Deutekom, Jaap Stoker, Paul Fockens, et al

Patient Preference and Adherence 2008, 2:157-162

Published Date: 30 April 2008